Oragenics Inc (OGEN): Question: What platform can exercise 4-d...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	40
Posts	1938
Boards Moderated	0
Alias Born	06/04/2009

PsyOpDude

Re: None

Wednesday, 10/10/2018 11:45:57 AM

Wednesday, October 10, 2018 11:45:57 AM

Question: What platform can exercise 4-digit after the dollar value trades? I know I can't do that...just wondering what level can take advantage of that

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent OGEN News

Oragenics Develops Automated Intranasal Device for Treating Concussed Patients • GlobeNewswire Inc. • 06/27/2024 12:30:40 PM
Oragenics, Inc. Announces Closing of Public Offering • GlobeNewswire Inc. • 06/26/2024 08:47:15 PM
Oragenics, Inc. Announces Pricing of Public Offering • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
Oragenics, Inc. Announces Proposed Public Offering • GlobeNewswire Inc. • 06/24/2024 10:43:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:00:24 PM
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 01:27:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 12:00:17 PM
Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer • GlobeNewswire Inc. • 05/22/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:00:41 PM
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine • GlobeNewswire Inc. • 05/17/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:00:22 PM
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial • GlobeNewswire Inc. • 05/16/2024 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 05:00:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:14:33 PM
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards • Business Wire • 04/19/2024 09:50:00 PM
Oragenics, Inc. Files 10K and Provides Company Update • Business Wire • 04/01/2024 01:05:00 PM
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion • Business Wire • 03/18/2024 11:00:00 AM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:24:29 PM
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion • Business Wire • 03/05/2024 12:45:00 PM
Oragenics Announces Closing of Public Offering • Business Wire • 03/01/2024 09:04:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:41:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:03:04 PM
Oragenics Announces Pricing of Public Offering • Business Wire • 02/28/2024 02:25:00 AM

More OGEN News

InvestorsHub NewsWire

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover